340B Patients Act would worsen 340B abuses by enriching large hospitals and middlemen at the expense of the patients in need.
MFN policies harm innovation and raise costs; 340B reforms stop hospitals and pharmacies from profiting at patients' expense.
Vague 340B rules enable hospitals to exploit the program, profiting off patients and insurers while driving up drug costs.
Large non-profit hospitals exploit tax breaks and federal programs, undermining charity care and distorting the healthcare market.
AB 1460 would change how the federal 340B Drug Pricing Program operates in the Golden State
HB 276 would change how the federal 340B Drug Discount Program operates in the Buckeye State
The 340B Drug Pricing Program has been used to inflate the profits of hospitals and pharmacies rather than providing savings.
HB 2048 will change how the federal 340B Drug Discount Program operates in Oklahoma
HB 2048 would change how the federal 340B Drug Discount Program operates in the Sooner State
